San Francisco, California — According to state and local development sources, Xaira Therapeutics plans to build out 73,075 square feet of new space in San Francisco. The company plans to occupy the new space in San Francisco, on or about July 1, 2025. According to the company website Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

To learn more about Xaira Therapeutics, visit http://xaira.com/

Company Contact:
Uplaksh Kumar, Chief Operating Officer
uplaksh.kumar@xaira.com
415-877-4887

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.